|

Atorvastatin Clinical Trials

5 actively recruiting trials across 1 location

▲ +1 trial since July 2026

Also known as: Lipitor

Pipeline

Phase 2: 2Phase 3: 2Phase 4: 1

Top Sponsors

  • University Health Network, Toronto1
  • Tampere University Hospital1
  • National Institute on Deafness and Other Communication Disorders (NIDCD)1
  • Gustave Roussy, Cancer Campus, Grand Paris1
  • Beijing Tsinghua Chang Gung Hospital1

Indications

  • Cancer4
  • Metastatic Prostate Cancer2
  • Prostate Cancer2
  • Prediabetic State (IGT)1
  • Metastatic Renal Cancer1

Other4 trials

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
Phase 2
Measuring Oncological Value of Exercise and Statin
Phase 3
The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes
Phase 4
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
Phase 3

Atlanta, Georgia1 trial

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Winship Cancer Institute at Emory University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.